Activity Of Sodium Bicarbonate Against Escherichia Coli
DOI:
https://doi.org/10.46966/msjar.v4i3.133Keywords:
: Sodium Bicarbonate (NaHco3), E. Coli, Gentamicin, Microbial Resistance, Antibiotics SensitivityAbstract
Background: Escherichia coli (E. coli) are one of the most common bacteria that can be pathogenic and develop resistance to various antibiotics by different ways, making them difficult to treat with standard therapies. So, using alternative strategies in management are urgent. Material and methods: The bacteria (E. coli) was isolated from urinary tract and wounds; cultured in three media (blood agar, macConkey agar, and eosin methylene blue agar). Sodium bicarbonate (SBC) with three concentrations (20%, 10%, and 5%) evaluated as antimicrobial agents against isolated E. coli by well diffusion method. The antibiotics discs (Gentamicin) were used by disc diffusion method as control agents. All the statistical analysis was done by using SPSS 26 software and Excel app. Results: Out of the 24 specimens in the study, 66.6% were women, while 33.4% were men with significant differences (P< 0.05). E. coli revealed 70.8 % sensitivity to gentamicin. 66.6 %, 62.5 %, and 58.33 % of E. coli were sensitive to 20%, 10%, and 5% SBC respectively. The mean comparison of inhibition zone of 20 % SBC 13.42± 11.75 mm with gentamicin 15± 6.43 mm showed no significant statistical differences (P= 56) that’s mean 20% SBC is equal in antibacterial activity to gentamicin. Other concentrations of SBC (10% and 5 %) also showed no significant differences compared to gentamicin (P= 21 and P= 0.16) respectively. Conclusions: The antibacterial activity of SBC makes it a promising candidate for the development of new antimicrobial agents.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Falah AL-Khikani

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















